Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation.
暂无分享,去创建一个
D. Heymann | Benjamin Ory | Dominique Heymann | Marta Tellez Gabriel | Lidia Rodriguez Calleja | Antoine Chalopin | B. Ory | A. Chalopin | M. T. Gabriel | L. Calleja
[1] Bo Lu,et al. Parylene membrane slot filter for the capture, analysis and culture of viable circulating tumor cells , 2010, 2010 IEEE 23rd International Conference on Micro Electro Mechanical Systems (MEMS).
[2] Nicole Pamme,et al. On-chip bioanalysis with magnetic particles. , 2012, Current opinion in chemical biology.
[3] S. Groshen,et al. Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells , 2010, Clinical Cancer Research.
[4] J. Fagerberg,et al. Clinical effects of a chimeric anti-EpCAM monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor in patients with metastatic colorectal carcinoma. , 2005, International journal of oncology.
[5] D. Krag,et al. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients , 2008, Breast Cancer Research.
[6] Yitshak Zohar,et al. A high-performance microsystem for isolating circulating tumor cells. , 2011, Lab on a chip.
[7] Sridhar Ramaswamy,et al. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.
[8] Hakho Lee,et al. Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection. , 2010, Nature nanotechnology.
[9] H. A. Pohl,et al. Some Effects of Nonuniform Fields on Dielectrics , 1958 .
[10] Wan Abu Bakar Wan Abas,et al. Benchtop Technologies for Circulating Tumor Cells Separation Based on Biophysical Properties , 2015, BioMed research international.
[11] Giuliano Mazzini,et al. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications , 2011, Expert review of molecular diagnostics.
[12] Eugene J. Lim,et al. Microfluidic, marker-free isolation of circulating tumor cells from blood samples , 2014, Nature Protocols.
[13] Tobias M. Gorges,et al. Circulating tumor cells as therapy-related biomarkers in cancer patients , 2013, Cancer Immunology, Immunotherapy.
[14] A. Fleischman,et al. Continuous flow magnetic cell fractionation based on antigen expression level. , 2006, Journal of biochemical and biophysical methods.
[15] Nada Jabado,et al. New technologies for the detection of circulating tumour cells. , 2010, British medical bulletin.
[16] J. Obrecht. [Cancer therapy]. , 1977, Deutsche medizinische Wochenschrift.
[17] Paul I. Okagbare,et al. Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor. , 2008, Journal of the American Chemical Society.
[18] M R Speicher,et al. The biology of circulating tumor cells , 2016, Oncogene.
[19] K. Pantel,et al. Circulating epithelial cells in patients with benign colon diseases. , 2012, Clinical chemistry.
[20] R. Eils,et al. Systemic spread is an early step in breast cancer. , 2008, Cancer cell.
[21] Nada Jabado,et al. Circulating tumor cells: detection, molecular profiling and future prospects , 2007, Expert review of proteomics.
[22] T. Molina,et al. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non‐small‐cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method , 2011, International journal of cancer.
[23] Eric S. Lander,et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing , 2012, Proceedings of the National Academy of Sciences.
[24] Daniel-Christoph Wagner,et al. Density Gradient Centrifugation Compromises Bone Marrow Mononuclear Cell Yield , 2012, PloS one.
[25] B. Groner,et al. Mammary gland biology and breast cancer , 2006, EMBO reports.
[26] F F Becker,et al. Separation of human breast cancer cells from blood by differential dielectric affinity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[27] B. Greene,et al. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood. , 2012, Clinical chemistry.
[28] M. Cher,et al. Circulating tumor cells: finding the needle in the haystack. , 2011, American journal of cancer research.
[29] K. Pantel,et al. Challenges in circulating tumour cell research , 2014, Nature Reviews Cancer.
[30] Carlos F. Gonzalez,et al. Harnessing dielectric forces for separations of cells, fine particles and macromolecules. , 2005, Journal of chromatography. A.
[31] C. Klein,et al. Parallel progression of primary tumours and metastases , 2009, Nature Reviews Cancer.
[32] Tony J. Pircher,et al. Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood , 2011, Journal of oncology.
[33] P. Hewett,et al. Identification of Early-Stage Colorectal Cancer Patients at Risk of Relapse Post-Resection by Immunobead Reverse Transcription-PCR Analysis of Peritoneal Lavage Fluid for Malignant Cells , 2006, Clinical Cancer Research.
[34] Kazunori Hoshino,et al. Microchip-based immunomagnetic detection of circulating tumor cells. , 2011, Lab on a chip.
[35] B. Ramaswamy,et al. Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients , 2014, Breast Cancer Research.
[36] Swee Jin Tan,et al. Microdevice for the isolation and enumeration of cancer cells from blood , 2009, Biomedical microdevices.
[37] Mitch Dowsett,et al. Cell filtration‐laser scanning cytometry for the characterisation of circulating breast cancer cells , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[38] John Hines,et al. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System , 2015, PloS one.
[39] S. Miyano,et al. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. , 2013, Cancer research.
[40] M. Caggana,et al. Development of a rare cell fractionation device: application for cancer detection , 2004, IEEE Transactions on NanoBioscience.
[41] Sridhar Ramaswamy,et al. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility , 2014, Science.
[42] A. Nicholson,et al. An assessment of diagnostic performance of a filter-based antibody-independent peripheral blood circulating tumour cell capture paired with cytomorphologic criteria for the diagnosis of cancer. , 2014, Lung cancer.
[43] H. Jung,et al. Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP). , 2011, Lab on a chip.
[44] V. Bobek,et al. Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation. , 2014, World journal of gastroenterology.
[45] Mari Mino-Kenudson,et al. Comparison of select cancer biomarkers in human circulating and bulk tumor cells using magnetic nanoparticles and a miniaturized micro-NMR system. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[46] A. Puisieux,et al. Metastasis: a question of life or death , 2006, Nature Reviews Cancer.
[47] W. Catalona,et al. Circulating giant macrophages as a potential biomarker of solid tumors , 2014, Proceedings of the National Academy of Sciences.
[48] Jaap M J den Toonder,et al. Circulating tumor cell isolation and diagnostics: toward routine clinical use. , 2011, Cancer research.
[49] R. Pethig,et al. ApoStream(™), a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood. , 2012, Biomicrofluidics.
[50] V. Valero,et al. Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system , 2012, International journal of cancer.
[51] Nicole Pamme,et al. Magnetism and microfluidics. , 2006, Lab on a chip.
[52] Peter R C Gascoyne,et al. Enrichment of putative stem cells from adipose tissue using dielectrophoretic field-flow fractionation. , 2008, Lab on a chip.
[53] A. Weiss,et al. Detection and characterization of carcinoma cells in the blood. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[54] T. Lin,et al. A Model for Resistance Growth During Protein Microfiltration , 2003 .
[55] Michael L Pearl,et al. Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer. , 2009, Gynecologic oncology.
[56] J R Siewert,et al. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. , 2002, Cytometry.
[57] Bo Lu,et al. 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood , 2011, Biomedical microdevices.
[58] Robert Rosenberg,et al. Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[59] H. Mellstedt,et al. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review. , 2012, Cancer treatment reviews.
[60] R. Pethig. Review article-dielectrophoresis: status of the theory, technology, and applications. , 2010, Biomicrofluidics.
[61] R. Butler,et al. Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. , 1993, Cancer research.
[62] L. Terstappen,et al. Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer. , 2004, Clinical chemistry.
[63] Heike Pohla,et al. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro. , 2003, The Journal of urology.
[64] B. Groner,et al. Conference on Common Molecular Mechanisms of Mammary Gland Development and Breast Cancer Progression , 2006 .
[65] J. Auman,et al. Colorectal cancer cell lines lack the molecular heterogeneity of clinical colorectal tumors. , 2010, Clinical colorectal cancer.
[66] J. Rosai,et al. Molecular detection of micrometastases and circulating tumor cells in solid tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[67] Gyan Bhanot,et al. Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines , 2012, PloS one.
[68] P. Jänne,et al. A new device for rapid isolation by size and characterization of rare circulating tumor cells. , 2011, Anticancer research.
[69] Udo Schumacher,et al. Establishment and characterization of a cell line from human circulating colon cancer cells. , 2015, Cancer research.
[70] M. Golightly,et al. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients , 2010, International journal of cancer.
[71] Maciej Zborowski,et al. Rare cell separation and analysis by magnetic sorting. , 2011, Analytical chemistry.
[72] C. Alix-Panabières,et al. Cellules tumorales circulantes : biopsie liquide du cancer , 2014 .
[73] Mark M Davis,et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device , 2009, Proceedings of the National Academy of Sciences.
[74] C. Chao,et al. The efficiency of Percoll and Ficoll density gradient media in the isolation of marrow derived human mesenchymal stem cells with osteogenic potential. , 2009, Chang Gung medical journal.